2019
DOI: 10.1073/pnas.1902623116
|View full text |Cite
|
Sign up to set email alerts
|

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk

Abstract: Multiple sclerosis (MS) is a chronic inflammatory, likely autoimmune disease of the central nervous system with a combination of genetic and environmental risk factors, among which Epstein-Barr virus (EBV) infection is a strong suspect. We have previously identified increased autoantibody levels toward the chloride-channel protein Anoctamin 2 (ANO2) in MS. Here, IgG antibody reactivity toward ANO2 and EBV nuclear antigen 1 (EBNA1) was measured using bead-based multiplex serology in plasma samples from 8,746 MS… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
125
0
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 147 publications
(159 citation statements)
references
References 42 publications
5
125
0
3
Order By: Relevance
“…The prevalent intracerebral EBV presence has been also demonstrated in a recent study where up to 93% of examined MS brain samples exhibit expression of EBV latent membrane protein 1 (LMP-1) and EBV-encoded RNA [44]. In terms of molecular mimicry, a recent study has shown partial complementary sequences and antibody cross-reactivity between EBNA-1 and newly proposed MS antigen of anoctamin 2 (CNS-based ion channel) [45]. A selected group of MS patients (approximately 32%) do present with increased reactivity towards Anoctamin 2 and may represent an EBV-induced MS sub-phenotype [46].…”
Section: Viral Infections and Virus-targeted Treatments In Multiple Smentioning
confidence: 73%
“…The prevalent intracerebral EBV presence has been also demonstrated in a recent study where up to 93% of examined MS brain samples exhibit expression of EBV latent membrane protein 1 (LMP-1) and EBV-encoded RNA [44]. In terms of molecular mimicry, a recent study has shown partial complementary sequences and antibody cross-reactivity between EBNA-1 and newly proposed MS antigen of anoctamin 2 (CNS-based ion channel) [45]. A selected group of MS patients (approximately 32%) do present with increased reactivity towards Anoctamin 2 and may represent an EBV-induced MS sub-phenotype [46].…”
Section: Viral Infections and Virus-targeted Treatments In Multiple Smentioning
confidence: 73%
“…EBNA1 is an important viral protein expressed in Burkitt's Lymphoma (Rowe et al, 2014) as well as during various latency phases (Latency I, I/II, II, III) in EBVassociated malignancies (Shannon-Lowe and Rickinson, 2019). EBNA1 has long been recognized as an antigen in MS in the contexts of both antibody (Comabella et al, 2010;Farrell et al, 2009;Hecker et al, 2016;Honarmand et al, 2015;Lunemann et al, 2008a;Mameli et al, 2014;Nociti et al, 2010;Sundqvist et al, 2012;Tengvall et al, 2019) and T cell targets (Lunemann et al, 2006;Ramasamy et al, 2020). Some studies include both B and T cell responses to EBNA1 (Comabella et al, 2012;Lunemann et al, 2008b;Lunemann et al, 2010;Mameli et al, 2016;Pender et al, 2017;Pender et al, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…Regarding environmental factors, it has been shown that migrants moving from a low-risk to a high-risk country have a higher than expected MS prevalence and vice versa (Ahlgren et al 2010, Ahlgren et al 2012, Berg-Hansen and Celius 2015, which supports the importance of lifestyle and environmental factors in risk of developing MS. Indeed, several factors have been shown to increase the risk of MS (Waubant et al 2019), in particular smoking and Epstein-Barr virus (EBV) infection (Hedström et al 2013, Hedström et al 2016, Tengvall et al 2019; Figure 3). On the contrary, the use of oral tobacco, high coffee and alcohol consumption could reduce the risk.…”
Section: Risk Factorsmentioning
confidence: 99%
“…Several lines of evidence support the relevance of myelin-reactive CD4 + T cells although direct evidence is still missing (Hohlfeld et al 2016). Recently, other plausible autoantigens in MS have been suggested (Ayoglu et al 2016, Planas et al 2018, such as anoctamin 2, a Ca 2+ activated chloride channel expressed in nerve cells (Ayoglu et al 2016, Tengvall et al 2019. Irrespective of target antigen, the presence of autoreactive lymphocytes, in combination with the strong major histocompatibility complex (MHC) association, implies that there is an autoimmune component to the disease.…”
Section: The Immune System and Msmentioning
confidence: 99%
See 1 more Smart Citation